Patient-reported outcomes in randomised controlled trials of prostate cancer: Methodological quality and impact on clinical decision making Review uri icon

Overview

MeSH Major

  • Decision Making
  • Patient Outcome Assessment
  • Prostatic Neoplasms
  • Research Design

abstract

  • In this report, we have investigated the methodological quality of PCa trials that have included a PRO assessment. We conclude that including PRO is critical to better evaluating the treatment effectiveness of new therapeutic approaches from the patient's perspective. Also, at least one-fifth of PRO RCTs in PCa have provided sufficient details to allow health policy makers and physicians to make a critical appraisal of results.

publication date

  • January 2014

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4150854

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2013.10.017

PubMed ID

  • 24210091

Additional Document Info

start page

  • 416

end page

  • 27

volume

  • 66

number

  • 3